Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Medicenna Therapeutics Corp. (T.MDN) had Weighted-Average Shares Outstanding (Diluted) of 69.64M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
-- |
|
-10.21M |
|
-- |
|
-- |
|
-- |
|
-2.94M |
|
-- |
|
-10.21M |
|
-10.21M |
|
-10.21M |
|
-10.21M |
|
-10.21M |
|
-10.21M |
|
-2.94M |
|
-2.94M |
|
69.64M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
69.64M |
-0.15 |
|
-0.15 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
14.05M |
|
-- |
|
-- |
|
-- |
|
10.24M |
|
3.81M |
|
3.77M |
|
3.81M |
|
69.64M |
|
| Cash Flow Statement Financials | |
-11.94M |
|
-- |
|
-- |
|
24.68M |
|
12.47M |
|
-12.20M |
|
0.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-267.85% |
|
-270.82% |
|
-72.67% |
|
-267.85% |
|
0.07 |
|
-0.17 |
|
-0.17 |
|